av/erytech-pharma--big.svg

COM:ERYTECH

PHAXIAM Therapeutics

  • Stock

EUR

Last Close

0.80

28/06 15:35

Market Cap

48.66M

Beta: -

Volume Today

27.49K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
cash per share
6.30
-
6.56
4.17%
4.72
28.11%
10.34
119.34%
7.49
27.57%
4.08
45.53%
2.42
40.74%
1.44
40.32%
1.25
13.23%
company equity multiplier
1.13
-
1.12
0.78%
1.26
12.20%
1.08
14.70%
1.15
7.10%
1.39
20.20%
3.03
118.66%
2.92
3.53%
1.95
33.26%
days of inventory outstanding
10.95
-
5.62
48.64%
2.68
52.27%
2.52
6.00%
15.22
503.44%
2.50
83.56%
days of payables outstanding
115.06
-
124.38
8.10%
89.44
28.09%
115.77
29.44%
181.64
56.90%
35.48
80.46%
29.83
15.93%
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
0.99
-
0.96
2.91%
0.98
1.52%
1.09
10.99%
0.88
19.29%
0.98
11.61%
1.06
8.89%
0.95
10.61%
-0.10
111.01%
effective tax rate
0.00
-
0.00
91.20%
-0.00
328.53%
0.00
119.59%
-0.00
158.49%
0.00
130.50%
-0.00
356.46%
-0.00
9.17%
1.78
4,782,897.78%
enterprise value multiple
-14.29
-
-9.09
36.37%
-3.49
61.64%
-4.52
29.62%
0.54
111.96%
-1.00
284.86%
-1.67
67.38%
-0.88
47.25%
0.61
169.09%
fixed asset turnover
free cash flow per share
-1.30
-
-2.13
63.66%
-2.43
13.67%
-1.47
39.34%
-2.98
102.70%
-3.54
18.60%
-2.87
18.71%
-2.41
16.22%
-1.03
57.37%
gross profit margin
interest coverage
-1.32K
-
-3.12K
136.89%
-5.60K
79.59%
-2.06K
63.21%
-4.85K
135.38%
-41.80
99.14%
-12.86
69.24%
-26.43
105.61%
-2.05
92.25%
inventory turnover
33.34
-
64.92
94.72%
135.99
109.49%
144.67
6.38%
23.97
83.43%
145.79
508.11%
long term debt to capitalization
0.01
-
0.00
73.44%
0.07
2,193.08%
0.01
84.96%
0.01
23.13%
0.13
1,416.36%
0.47
266.52%
0.51
7.55%
0.30
40.04%
net income per ebt
1.00
-
1.00
0.21%
1.00
0.07%
1.00
0.06%
1.00
0.01%
1.00
0.01%
1.00
0.01%
1.00
0.00%
-0.78
177.81%
net profit margin
operating cash flow per share
-1.23
-
-2.10
70.05%
-2.21
5.30%
-1.38
37.58%
-2.19
58.98%
-2.41
10.29%
-2.81
16.50%
-2.40
14.82%
-1.02
57.26%
operating profit margin
payables turnover
3.17
-
2.93
7.49%
4.08
39.06%
3.15
22.74%
2.01
36.26%
10.29
411.89%
12.24
18.95%
pretax profit margin
price fair value
4.44
-
3.79
14.57%
3.08
18.87%
1.83
40.57%
0.77
57.91%
1.40
82.43%
4.93
250.68%
2.20
55.37%
0.48
77.97%
receivables turnover
return on assets
-0.22
-
-0.28
29.81%
-0.49
72.05%
-0.17
64.76%
-0.23
32.62%
-0.53
132.09%
-0.91
72.48%
-0.81
11.62%
-0.00
99.38%
return on capital employed
-0.25
-
-0.33
33.60%
-0.58
76.28%
-0.17
70.99%
-0.30
76.21%
-0.65
119.13%
-1.35
107.60%
-1.21
10.36%
-0.08
93.22%
return on equity
-0.25
-
-0.32
28.79%
-0.61
93.04%
-0.18
69.94%
-0.26
42.04%
-0.73
178.97%
-2.76
277.14%
-2.35
14.74%
-0.01
99.59%
total debt to capitalization
0.02
-
0.01
29.62%
0.07
402.95%
0.02
79.26%
0.01
11.37%
0.14
935.47%
0.51
258.83%
0.53
3.50%
0.37
30.42%

All numbers in EUR (except ratios and percentages)